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Emergency procedures on the descending thoracic
aorta in the endovascular era
Marc E. Mitchell, MD, Fred W. Rushton Jr, MD, A. Bradley Boland, MD, Taylor C. Byrd, BS, and
Zachary K. Baldwin, MD, Jackson, Miss
Background: Thoracic endovascular aortic repair (TEVAR), initially developed for the treatment of degenerative
aneurysms of the descending thoracic aorta, has been applied to the entire spectrum of descending thoracic aortic
pathology in both the elective and emergent settings. This single center study evaluates the effectiveness of TEVAR for
the treatment of acute surgical emergencies involving the descending thoracic aorta, including traumatic aortic disruption
(TAD), ruptured descending thoracic aneurysm (RDTA), and acute complicated Type B dissection (cTBD).
Methods: A retrospective review of the medical records of all patients undergoing emergent TEVAR at the University of
Mississippi Medical Center between August 2007 and November 2010 was undertaken. Patients were studied for 30-day
survival, complications, type of device used for the repair, and technical aspects of the procedure.
Results: A total of 44 patients (59% male) with an average age of 49 years (range, 16-87 years) underwent emergent
TEVAR during the study period. The technical success rate was 100%, with no patient requiring emergent open surgery
for conditions involving the descending thoracic aorta at our institution during the study period. The majority (73%) of
the repairs were accomplished using commercially available thoracic stent grafts. Abdominal endograft proximal
extension cuffs were used in 12 (38%) of the 32 patients undergoing repair of TAD. Twenty-one patients (48%) required
coverage of the left subclavian artery, two (10%) of whom subsequently required subclavian artery revascularization.
Procedure-related complications included two strokes, one spinal cord ischemia, one unintentional coverage of the left
carotid artery, one episode of acute renal failure, and three access site injuries. One patient undergoing repair of TAD had
collapse of the stent graft in the early postoperative period.He was successfully treated by placement of an additional stent
graft. Seven patients (16%) died within 30 days of surgery. Three of the deaths occurred in patients who had successfully
undergone repair of a TAD and died of associated injuries.
Conclusions: Emergent TEVAR has become the treatment of choice for acute surgical emergencies involving the
descending thoracic aorta. Short-termmorbidity andmortality compare favorably with historic results for emergent open
surgical procedures on the descending thoracic aorta. Survival is highest in patients undergoing repair of TAD. Using
current endograft technology, nearly all emergent conditions of the descending thoracic aorta can be successfully treated
with TEVAR. (J Vasc Surg 2011;54:1298-302.)
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aCatastrophes involving the descending thoracic aorta
have long been particularly challenging for surgeons. Many
patients do not survive the initial event and never undergo
an attempt at repair. Emergent open operative repair of the
descending thoracic aorta, the traditional gold standard, is
associated with significant operative mortality and morbid-
ity, making these procedures some of the riskiest and most
difficult undertaken by vascular surgeons.1,2
Initially developed for the elective repair of degene-
rative aneurysms, thoracic endovascular aortic repair
(TEVAR) has quickly become the treatment of choice for
all conditions, both elective and emergent, involving the
descending thoracic aorta.1,3-6 The result has been a de-
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1298rease in both operative mortality and morbidity for pa-
ients with these conditions. The current study looks at the
xperience of a single center with emergent endovascular
epair of descending thoracic aortic catastrophes.
ETHODS
A retrospective review of all patients undergoing emer-
ent procedures on the descending thoracic aorta at the
niversity of Mississippi Medical Center between August
007 andNovember 2010was performed. All patients with
cute surgical emergencies involving the descending tho-
acic aorta, including traumatic aortic disruption (TAD),
uptured descending thoracic aneurysm (RDTA), and
cute complicated Type B dissection (cTBD)were included
n the study. Acute cTBD was defined as visceral or lower
xtremity malperfusion syndrome or aortic rupture in the
etting of an acute Type B aortic dissection unresponsive to
edical therapy.
Patients with complications related to Type A aortic
issections or chronic Type B aortic dissections were ex-
luded. Patients with symptomatic or rapidly expanding,
ut not ruptured, descending thoracic aneurysms were
xcluded. Patients with minimal TAD not requiring repair,
s defined by the Society for Vascular Surgery clinical
ractice guidelines were excluded.1
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Volume 54, Number 5 Mitchell et al 1299Medical records, preoperative computed tomography
(CT) scans, and intraoperative imaging studies were re-
viewed for all patients. Data collected included demo-
graphic information, patient comorbid conditions, details
of the procedure, and the patient’s hospital course. The
primary outcome measures were technical success,
procedure-related mortality, and morbidity. The deci-
sion regarding the type of device used, whether or not to
give heparin, or to employ spinal drainage was left to the
discretion of the operating surgeon.
In all cases, the exact nature of the aortic catastrophe
was diagnosed by CT scan prior to TEVAR. Patients pre-
senting in extremis and deemed not to be surgical candi-
dates, and those declining treatment were excluded from
the study. Endovascular technical success was defined as
successful treatment of the underlying aortic pathology
with TEVAR. Patients were informed that the use of en-
dografts for the treatment of these conditions represents an
“off label” use of the device. The Institutional Review
Board of the University of Mississippi Medical Center
approved the retrospective review.
RESULTS
During the study period, all patients with catastrophes
of the descending thoracic aorta requiring emergent surgi-
cal intervention were treated by vascular surgeons using
commercially available thoracic endografts or abdominal
endograft proximal extension cuffs that are stocked in our
operating room. All patients except one were treated with
Excluder or TAG (W. L. Gore, Flagstaff, Ariz) endografts.
The study group comprised 44 patients. Patient age, gen-
der, and the distribution of aortic pathology are detailed in
Table I. Patients with TAD were younger than those with
RDTA and cTBD.
No patients underwent open repair during the study
period, and technical success was achieved in all 44 patients
undergoing endovascular repair. In eight patients (18%),
percutaneous femoral artery access was used. Preoperative
spinal drainage was not used in any patient. Heparin ad-
ministration was inconsistent.
Seven patients in the study group died, resulting in an
Table I. Distribution of aortic pathology, age, gender, sub
and mortality
Type of aortic
pathology (N)
Mean age
(range) Male
Subclavian artery
coverage
TAD (n  32) 43 (16-77) 21 (70%) 16 of 32 (50%)
RDTA (n  7) 68 (54-87) 2 (29%) 3 of 7 (43%)
cTBD (n  4) 67 (50-77) 3 (75%) 2 of 4 (50%)
Spontaneous distal
aortic tear (n  1) 42 0 (0%) 0 of 1 (0%)
Total (n  44) 49 (16-87) 26 (59%) 21 of 44 (48%)
cTBD, Complicated type B dissection; RDTA, ruptured descending thoracioverall 30-day survival of 84%, ranging from 57% in patients with RDTA to 91% in patients with TAD (Table I). The
eaths are detailed in Table II. The three deaths in the TAD
roup were the result of associated injuries, not the aortic
ransaction.
Two patients in the RDTA group had aortoesophageal
stulae. One was related to an esophageal perforation sec-
ndary to dilatation of the esophagus, with subsequent
seudoaneurysm formation and rupture. The ruptured
seudoaneurysm was successfully treated, but the patient
as subsequently discovered to have cancer, and care was
ithdrawn. The other resulted from the spontaneous rup-
ure of a mycotic aortic pseudoaneurysm into the esopha-
us. This patient was successfully treated with TEVAR. The
sophagus was debrided, closed, and a muscle flap inter-
osed between the esophagus and aorta. He is alive and
ell 2 years later.
The other two deaths in the RDTA group were in
atients with significant cardiac disease. One presented in
hock, was resuscitated, had successful endovascular exclu-
ion of the RDTA, but suffered an acute myocardial infarc-
ion and died of cardiac failure in the operating room. The
ther died of a myocardial infarction in the early postoper-
tive period after successful TEVAR. The death in the
TBD group was the result of postoperative pneumonia
nd respiratory failure after successful TEVAR.
All patients with RDTA and cTBD were treated using
ommercially available thoracic endografts, while 38% of
atients with TAD were treated with abdominal endograft
roximal extension cuffs (Table I). When abdominal en-
ograft proximal extension cuffs were used, a mean of 3.8
evices were required, compared with only 1.5 devices
hen thoracic endografts were used. The decision regard-
ng the type of device to use was left to the discretion of the
perating surgeon, and was based on the patient’s anat-
my. Abdominal endograft proximal extension cuffs were
sed primarily in cases of small diameter descending tho-
acic aortas.
Two patients in the TAD group required construction
f an iliac conduit for endograft delivery. One patient had
n iliac system that was too small to accommodate the
elivery device. The other had a small thoracic aorta that
ian artery coverage, type and number of devices used,
ype of device used (N)
Mean number of
devices used (range) 30-day survival
racic (n  20)
ominal cuff (n  12)
Thoracic 1.4 (1-3)
Abdominal cuff 3.8
(2-6)
29 of 32 (91%)
racic (n  7) Thoracic 1.7 (1-2) 4 of 7 (57%)
racic (n  4) Thoracic 1.8 (1-3) 3 of 4 (75%)
racic (n  1) Thoracic 1 1/1 (100%)
racic (n  32)
ominal cuff (n  12)
Thoracic 1.5 (1-3)
Abdominal cuff 3.8
(2-6)
37 of 44 (84%)
rysm; TAD, traumatic aortic disruption.clav
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November 20111300 Mitchell et alcuffs. A conduit was used to access the common iliac artery
so the short delivery system of the abdominal endograft
proximal extension cuff would reach the proximal descend-
ing thoracic aorta. Three patients required iliac angioplasty
and stenting in order to accommodate the device delivery
system.
The left subclavian artery was covered in 48% of the
cases (Table I). The frequency of subclavian artery coverage
was similar regardless of the type of aortic pathology being
treated. Two (10%) of the 21 patients in whom the subcla-
vian artery was covered required revascularization. One was
performed acutely at the time of repair of the TAD because
of poor collateral flow to the left arm. The other patient had
persistent ischemic hand pain. Carotid to subclavian bypass
was performed 5 weeks after TEVAR with complete reso-
lution of symptoms.
Nine patients (20%) had procedure-related complica-
tions (Table II). There were three access site complications.
One patient suffered a tear of the external iliac artery, which
was reconstructed with a graft. Two others had early post-
operative thrombosis of the common femoral artery requir-
ing thrombectomy. One of these patients developed a
superficial wound infection.
Two patients in the TAD group had device-related
complications. One had a small aorta that was repaired with
an oversized thoracic endograft. The graft collapsed in the
early postoperative period. An additional endograft was
placed, with full expansion. In one patient, the left com-
mon carotid artery was nearly completely covered by the
endograft, and flow significantly diminished. Open expo-
Table II. Details of mortality and complications
Patient Type of aortic pathology
25-year-old male TAD and closed head injury
60-year-old male TAD with closed head injury and
pulmonary contusion
39-year-old male TAD with multiple intra-abdominal
34-year-old male TAD
19-year-old male TAD
44-year-old male TAD
44-year-old female TAD
24-year-old male TAD
77-year-old female cTBD with visceral malperfusion
50-year-old male cTBD with visceral malperfusion
77-year-old male cTBD with visceral malperfusion
87-year-old female RDTA
84-year-old female RDTA
70-year-old male RDTA (pseudoaneurysm secondary t
esophageal cancer)
54-year-old female RDTA
cTBD, Complicated type B dissection; RDTA, ruptured descending thoracisure of the common carotid artery was performed for petrograde delivery of a balloon expandable bare metal
tent, which successfully restored flow. The patient did well
nd has had no neurologic symptoms or evidence of carotid
tenosis 1 year after treatment.
Two patients suffered neurologic complications. One
atient with an RDTA had a stroke 4 days postoperatively.
he was discovered to have a high grade internal carotid
rtery stenosis, underwent carotid endarterectomy, and
ubsequently had full neurologic recovery. The other de-
eloped spinal ischemia and lower extremity weakness after
reatment of a cTBDwith visceral malperfusion syndrome. A
umbar drain was placed, and the lower extremity weakness
ecovered fully. The same patient subsequently had a stroke
anifest by upper extremity weakness which eventually im-
roved. One patient with a cTBD and visceral malperfusion
ad progression of renal failure despite successful interven-
ion, and ultimately became dialysis-dependent.
ISCUSSION
The widespread application of TEVAR to the treat-
ent of acute surgical emergencies involving the descend-
ng thoracic aorta has resulted in a dramatic decrease in
oth operative mortality and morbidity for these condi-
ions.2 The results of the current study compare favorably
ith other published reports detailing the use of TEVAR in
hese conditions, and compare favorably with historical
ata for open surgical repair.
Over the last several years, there has been a rapid shift to
EVAR for the treatment of TAD. Open repair of TAD is
ssociated with an operative mortality of up to 28% and
Death or complication
Death from associated injuries
Death from associated injuries
es Death from associated injuries
Endograft collapse
Unintentional coverage of left common carotid
artery
Left upper extremity ischemia after coverage of left
subclavian artery
Left upper extremity ischemia after coverage of left
subclavian artery
Femoral artery thrombosis
Death from pneumonia and respiratory failure
Stroke and spinal ischemia
Renal failure
Death from myocardial infarction and intraoperative
cardiac failure
Torn external iliac artery
Death from myocardial infarction on postoperative
day five
Death from esophageal cancer
Femoral artery thrombosis, superficial wound
infection and stroke
rysm; TAD, traumatic aortic disruption.injuri
oaraplegia rate of 16%.6-9 Our mortality of 9% with no
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TEVAR is similar to the results of a systematic review of the
literature, demonstrating an overall mortality rate of 9% and
paraplegia rate of 3% in 7768 patients undergoing TEVAR
for TAD.10 Recently published Society for Vascular Sur-
gery practice guidelines suggest that TEVAR should be the
standard therapy for the treatment of TAD.1
Contemporary series have demonstratedmortality rates
of up to 30% for open repair of RDTA.11-13 Our series had
a slightly higher mortality rate of 43%, but the number of
patients with RDTA was small. Two of the deaths were
expected; one in a patient who presented in shock and the
other in a patient with terminal esophageal cancer.
Medical therapy has long been the standard for uncom-
plicated type B aortic dissection,14 with surgery reserved for
patients who fail medical therapy. Open surgery in the
setting of cTBD has a reported mortality upwards of
30%.15,16 Although only four patients in our series had
cTBD, our results are favorable compared with open repair.
No patient suffered permanent paraplegia in our series,
which is similar to the reported incidence in other series of
patients undergoing emergency TEVAR.2,17 Preprocedure
spinal drainage was not used in this series. Because of the
low incidence of spinal ischemia in TEVAR for TAD, we do
not believe it is indicated in these patients. Patients with
RDTA are typically unstable, and usually there is not time
for spinal drain placement. In the cases of cTBD, prepro-
cedure spinal drain placement may be advantageous. In-
deed, the single case of spinal ischemia in this series was in
a patient with cTBD. Fortunately, he recovered completely
after postoperative drain placement, as has been reported
previously.18
The appropriate use of heparin in these conditions has
not yet been determined.1 Heparin use varied significantly
in our series. Heparin was avoided in patients with head
injuries and significant bleeding. Many patients received
“low dose” heparin during the procedure. The experience
and judgment of the operating surgeon is paramount in
determining the appropriate use of heparin in these pa-
tients.
One can argue that the benefits of TEVAR in an
emergency setting are even greater than those seen with
elective procedures. The overall 30-day mortality of 16% in
this cohort of patients undergoing emergent repair, includ-
ing no cases of permanent paraplegia, represents significant
improvement compared with historical results of open sur-
gical repair for these conditions. The results approach the
10% operative mortality seen with elective open surgery on
the descending thoracic aorta.19,20 While elective TEVAR
offers a significant reduction in mortality and morbidity
compared with elective repair of thoracic aneurysm, the
reduction in mortality and morbidity seen with emergency
TEVAR is even greater.
The most striking aspect of the current study is the fact
that all emergent operations performed upon the descend-
ing thoracic aorta were done using TEVAR. There were no
open repairs of TAD, RDTA, or cTBD during the study
time frame. All attempts at TEVAR were successful. Whilet is obvious that not all patients are candidates for TEVAR
nd that not all attempts at TEVAR will be successful, this
tudy demonstrates that the vast majority of patients with
cute surgical emergencies of the descending thoracic aorta
an be successfully treated using TEVAR. As newer devices
re developed designed specifically for TAD and cTBD, the
esults will only continue to improve.
ONCLUSION
Using currently available commercial thoracic en-
ografts or abdominal endograft proximal extension cuffs
hat are designed for elective repair of degenerative aneu-
ysms, emergent TEVAR can be performed in most pa-
ients with catastrophes of the descending thoracic aorta.
hort-term results compare favorably with historic results
or emergent open surgical procedures on the descending
horacic aorta. Emergent TEVAR has become the treat-
ent of choice for acute surgical emergencies involving the
escending thoracic aorta, and should be considered the
rst line of therapy for all emergent conditions involving
he descending thoracic aorta.
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Dr Jeff B. Dattilo (Nashville, Tenn). I’d like to thank the
Society for the privilege of discussing this well written paper. I
appreciate the timeliness with which the authors offered the paper
to me for review. DrMitchell and his esteemed colleagues from the
University of Mississippi have concisely reported their single insti-
tution retrospective data concerning use of TEVAR in the treat-
ment of descending thoracic emergencies. Their data involve three
unique patient populations with three distinct surgical and medical
pathophysiologies: traumatic aortic disruption, rupture of de-
scending thoracic aortic aneurysms, and complicated type B dis-
section. Their results demonstrate improved outcomes with regard
to major morbidity and mortality with use of currently available
commercial aortic devices as compared to historic open controls.
They suggest that this technology can be safely used in all of these
emergent clinical scenarios. Use of this technology required cov-
erage of the subclavian artery in half of the patients with a resultant
paucity of post intervention subclavian artery revascularization,
which is not necessarily dissimilar to many published reports.
I have three questions: With the nearly infectious use of
endoluminal therapy for treating traumatic aortic disruptions,
what are the author’s thoughts on conservative, nonoperative
management of these injuries? Do you use a scoring system of the
intimal or aortic disruption with protocols to determine which
patients to intervene upon acutely?
Second, I noticed in your ruptured descending thoracic aortic
group, you had two individuals well into there 80s die subsequent
to graft placement. You had seven patients in that group. Is your
vascular unit evaluating the advanced-aged patient and there pre-
operative risk to determine if endovascular therapy should be
offered at all in these patients?
Last, I’d like your thoughts on the development of second and
third generation aortic stent grafts particularly designed for the
acutely angled aortic arch, meaning the typical, young patients
most often seen with acute traumatic arch injury. Are we obligated
as a subspecialty to better understand the long-term ramifications
of having these stents in this exceptionally dynamic position for
what could be several decades in these young patients?
Dr Mitchell, it was a pleasure to have the opportunity toDr Marc E. Mitchell. Thank you, Dr Dattilo. We are seeing
ore andmore traumatic aortic disruptions, and I believe there are
wo reasons. Most patients with any significant degree of trauma
ave a CT scan of the chest and CT scan technology has improved
o the point where we are identifying many minor aortic injuries
ow which we never would have picked up in the past. In our
ractice, we probably watch or treat conservatively more aortic
njuries than we operate on. In preparing this manuscript, we
eviewed the CT scans of all the patients we treated and in
etrospect, there was only one patient who probably could have
een treated nonoperatively. The SVS recently published guide-
ines for the treatment of traumatic aortic injuries. They are some-
hat subjective, but we tend to follow those guidelines and do not
perate on patients with minor intimal injuries.
The second question is about elderly patients with ruptured
neurysms. We did not specifically look at patients with reputed
neurysms who we not operated on, but during the study period,
hey were probably as many if not more patients who were treated
xpectantly than were offered surgery. We don’t have a protocol,
ut we look at each patient individually. There are patients with
ittle chance of surviving an operation, but the family still insists on
urgery. Conversely, there are patients in whom we recommend
urgery, but they refuse.
The third question is about new devices. As was made obvious
rom the complication of a graft collapse in a young trauma patient,
here are certainly limitations to the current devices. I have no
oubt that the newer generation of devices will make those com-
lications less common and will improve our ability to treat these
atients.
The question about leaving a stent in a young patient’s aorta
or decades is very interesting. I’m not sure if we will be operating
n these patients in several years and replacing their aortas with
rafts. Even if that is the case, I believe TEVAR in the acute setting
s a better option than doing an open repair in a critically ill patient
ith multisystem trauma. It may turn out that the endovascular
epair is a type of bridge therapy in some patients. The benefits of
EVAR in the face of multisystem traumamake it superior to open
epair and I believe it’s the right thing to do.
